Publications by authors named "Hongxia Lin"

Claim this Profile
T
The role of miR-1180-3p in breast cancer and its effect on the cell functions of breast cancer cells.
Jiayuan Mao, Yinxiang Xu, Hongxia Lin, Weixia Zhou, Man Tang

Nucleosides Nucleotides Nucleic Acids· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalytic oxidation of volatile organic compounds over supported noble metal and single atom catalysts: A review.
Honghong Zhang, Zhiwei Wang, Hongxia Lin, Yuxi Liu, Hongxing Dai

J Environ Sci (China)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Causal Relationship Between Serum Metabolites and Allergic Diseases: Mendelian Randomization Analysis.
Yanli Qiu, Bing Zhang, Haocong Chen, Jialin Zhang, Yu Zhang, Hongxia Lin

Clin Exp Allergy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-informed Drug Development (MIDD) Approach to Support Biopharmaceutical Development of Iberdomide.
Caroline Sychterz, Ping Chen, Ajay Saxena, Hongxia Lin, Lu Chen

AAPS J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population pharmacokinetic analysis to evaluate the impact of renal impairment on the pharmacokinetics of iberdomide.
Ping Chen, Hongxia Lin, Yongjun Xue, Mark Thomas, Alice Wang

J Pharm Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phytohormones involved in vascular cambium activity in woods: current progress and future challenges.
Wenjing Ding, Chencan Wang, Man Mei, Xiaoxu Li, Yuqian Zhang, Hongxia Lin, Jinxing Lin

Front Plant Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Factors That Affect Mortality Patients with Bloodstream Infection.
Chunrong Huang, Yulian Gao, Hongxia Lin, Qinmei Fan, Ling Chen

Infect Drug Resist· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA257 promotes secondary growth in hybrid poplar.
Yayu Guo, Shuhang He, Hou-Ling Wang, Hongxia Lin, Yuqian Zhang

Plant Physiol Biochem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
Kristen R Spencer, Daniella E Portal, Joseph Aisner, Mark N Stein, Jyoti Malhotra, Hongxia Lin

Oncotarget· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graphitic carbon nitride-based photocatalysts in the applications of environmental catalysis.
Hongxia Lin, Jinmo Wu, Fan Zhou, Xiaolong Zhao, Pengfei Lu

J Environ Sci (China)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age group on bloodstream infection risk evaluation in immunosuppressed patients: a retrospective, single-centre, 5-year cohort study.
Hongxia Lin, Yulian Gao, Yanli Qiu, Wei Du, Haixing Zhu

Aging Clin Exp Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study.
Quincy Chu, Natasha B Leighl, Veerle Surmont, Carla van Herpen, Anne Sibille, Hongxia Lin

JTO Clin Res Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Risk Factors of Carbapenem-Resistant Gram-Negative Bacteria Bloodstream Infection in Immunosuppressed Patients: A 7-Year Retrospective Cohort Study.
Yulian Gao, Hongxia Lin, Yumin Xu, Yijin Yao, Dake Shi

Infect Drug Resist· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prognostic Factors of Bloodstream Infection in Immunosuppressed Elderly Patients: A Retrospective, Single-center, Five-year Cohort Study.
Hongxia Lin, Yulian Gao, Yanli Qiu, Haixing Zhu, Shengxiong Zhang

Clin Interv Aging· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential value of tumor stiffness and sE-cadherin in predicting the response to neoadjuvant therapy in HER2-positive breast cancers.
Weixia Zhou, Meng Wu, Hongxia Lin, Wanjun Chen, Guowen Lu, Yaling Chen

Future Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics of Bloodstream Infection in Immunosuppressed Patients: A 5-Year Retrospective Cohort Study.
Hongxia Lin, Lili Yang, Jie Fang, Yulian Gao, Haixing Zhu

Front Cell Infect Microbiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion.
Hongxia Lin, Lei Ni

Med Clin (Barc)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.
Antoinette R Tan, Nancy Chan, Brian F Kiesel, Mark N Stein, Rebecca A Moss, Hongxia Lin, Yong Lin

Cancer Chemother Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation.
Kandi Xu, Huize Han, Yexin Luo, Hong Ye, Hongxia Lin

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors.
Mark N Stein, Susan Goodin, Murugeson Gounder, Darlene Gibbon, Rebecca Moss, Diana Lindquist, Hongxia Lin

Invest New Drugs· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors.
Janice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, Kristen Spencer, Daniella Portal, Hongxia Lin

Cancer Chemother Pharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma.
Gulam M Rather, Siang-Yo Lin, Hongxia Lin, Zoltan Szekely, Joseph R Bertino

Front Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics.
Xin Yu, Samuel Kogan, Ying Chen, Ashley T Tsang, Tracy Withers, Hongxia Lin

Clin Cancer Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Au-Pd/mesoporous FeO: Highly active photocatalysts for the visible-light-driven degradation of acetone.
Hongxia Lin, Yuxi Liu, Jiguang Deng, Kunfeng Zhang, Xing Zhang

J Environ Sci (China)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated matriptase as a target to treat breast cancer with a drug conjugate.
Gulam M Rather, Siang-Yo Lin, Hongxia Lin, Whitney Banach-Petrosky, Kim M Hirshfield, Chen-Yong Lin

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis